P. Cogram

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
P. Cogram, Peter Frank Cogram, Patricia Cogram
Publication record
42 papers · 1,277 citations · H-index 17

PAPERS

Microbiome alterations are associated with apolipoprotein E mutation in Octodon degus and humans with Alzheimer’s disease
20245 citationsauthor #10
Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease
202215 citationsauthor #6
Alteration of Fatty Acid Profile in Fragile X Syndrome
20225 citationsauthor #14
Spatial maps and oscillations in the healthy hippocampus of Octodon degus, a natural model of sporadic Alzheimer’s disease
20222 citationsauthor #7
Genome Sequencing Variations in the Octodon degus, an Unconventional Natural Model of Aging and Alzheimer's Disease
202211 citationsauthor #2
Comparison of degu (Octodon degus), Naked Mole Rat, Mouse and Human genomes identified common hallmarks of aging and Alzheimer's Disease
20220 citationsauthor #1
The inhibition of NCS-1 binding to Ric8a rescues fragile X syndrome mice model phenotypes
20224 citationsauthor #1
Brain cell signaling abnormalities are detected in blood in a murine model of Fragile X syndrome and corrected by Sigma‐1 receptor agonist Blarcamesine
20223 citationsauthor #1
Effects of the sigma-1 receptor agonist blarcamesine in a murine model of fragile X syndrome: neurobehavioral phenotypes and receptor occupancy
202122 citationsauthor #16
Altered Gut Microbiota in a Fragile X Syndrome Mouse Model
202128 citationsauthor #7
Reversal of behavioural phenotype by the cannabinoid-like compound VSN16R in fragile X syndrome mice.
20216 citationsauthor #6
Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X mice
20209 citationsauthor #1
From genes to cognition: Octodon degus, an animal model for AD translational research
20200 citationsauthor #7
Dementia in Latin America: Paving the way toward a regional action plan
202096 citationsauthor #13
Repurposing available drugs for neurodevelopmental disorders: The fragile X experience
201932 citationsauthor #8
Gaboxadol Normalizes Behavioral Abnormalities in a Mouse Model of Fragile X Syndrome
201938 citationsauthor #1
Dementia in Latin America
2018115 citationsauthor #12
Evaluation of the rodent Octodon degus as a pre-clinical model of liver fibrosis
20180 citationsauthor #2
Gaboxadol Normalizes Behavioral Abnormalities in a Mouse Model of Fragile X Syndrome (P1.323)
20181 citationsauthor #1
Editorial: Human and Animal Models for Translational Research on Neurodegeneration: Challenges and Opportunities From South America
201812 citationsauthor #5
The long‐lived Octodon degus as a rodent drug discovery model for Alzheimer's and other age‐related diseases
201825 citationsauthor #7
Edinburgh Research Explorer Dementia in Latin America
20180 citationsauthor #12
5.16 AMO-01 in the SHANK3 Knockout Transgenic Mouse Model of Phelan Mcdermid Syndrome
20171 citationsauthor #5
[P3–147]: OCTODON DEGUS, A HOPE FOR ALZHEIMER's?
20170 citationsauthor #1
Capacity and mechanisms of uptake of silver by jarosite family minerals
20172 citationsauthor #1
Retracted: Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566
20177 citationsauthor #12
Brain Transcriptome Sequencing of a Natural Model of Alzheimer's Disease
201712 citationsauthor #14
Multiple Behavior Phenotypes of the Fragile-X Syndrome Mouse Model Respond to Chronic Inhibition of Phosphodiesterase-4D (PDE4D)
20170 citationsauthor #2
Multiple Behavior Phenotypes of the Fragile-X Syndrome Mouse Model Respond to Chronic Inhibition of Phosphodiesterase-4D (PDE4D)
201761 citationsauthor #2
Natural AD-Like Neuropathology in Octodon degus: Impaired Burrowing and Neuroinflammation.
201526 citationsauthor #12
NNZ-2566, a Novel Analog of (1–3) IGF-1, as a Potential Therapeutic Agent for Fragile X Syndrome
201570 citationsauthor #7
Metadoxine In ADHD and fragile X syndrome: a novel mechanism of action
20142 citationsauthor #5
Distribution of AGG interruption patterns within nine world populations.
201423 citationsauthor #13
CITED2 and PBX1 in human adrenal development and disease
20091 citationsauthor #5
CBP/p300-interacting transactivator, with Glu/Asp-rich C-terminal domain, 2, and pre-B-cell leukemia transcription factor 1 in human adrenal development and disease.
200935 citationsauthor #5
CBP / p 300-Interacting Transactivator , with Glu / Asp-Rich C-Terminal Domain , 2 , and Pre-B-Cell Leukemia Transcription Factor 1 in Human Adrenal Development and Disease
20095 citationsauthor #5
Inositol and protein kinase C in the prevention of neural tube defects
20080 citationsauthor #1
Rap1 Regulates the Formation of E-Cadherin-Based Cell-Cell Contacts
2004267 citationsauthor #3
Specific isoforms of protein kinase C are essential for prevention of folate-resistant neural tube defects by inositol.
200367 citationsauthor #1
D-chiro-inositol is more effective than myo-inositol in preventing folate-resistant mouse neural tube defects.
200258 citationsauthor #1
Sonic hedgehog and the molecular regulation of mouse neural tube closure.
2002162 citationsauthor #2
Neurulation and neural tube closure defects.
200049 citationsauthor #2

TIMELINE

2000 49 citations

2002 220 citations

2003 67 citations

2004 267 citations

2008 0 citations

2009 41 citations

2014 25 citations

2015 96 citations

2017 83 citations

2018 153 citations

2019 70 citations

2020 105 citations

2021 56 citations

2022 40 citations

2024 5 citations

P. Cogram

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT